Logo Image
News
Media
PodcastsCase Based Peer PerspectivesClinical Forum InsightsInsightsInvestigator PerspectivesMedical World NewsPeer ExchangePeers & PerspectivesShortsSpecial ReportVideos
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement
|Articles|August 3, 2011

Contraception Lecture

Author(s)Fariha Farooq, FCPS
Advertisement

Advertisement
Contraception

Related Content

Advertisement
The top headlines in women's health from May 2026

The top headlines in women's health from May 2026

ByJoshua Fitch, Senior Editor
May 29th 2026
Mifepristone via telehealth, mail order can continue amid lawsuit, Supreme Court says | | Image credit: © SolsticeStudio - stock.adobe.com

Mifepristone via telehealth, mail order can continue amid lawsuit, Supreme Court says

ByJoshua Fitch, Senior Editor
May 15th 2026
Ovaprene phase 3 interim data supports potential of monthly hormone-free contraceptive | Image credit: Stock.Adobe.com

Ovaprene phase 3 interim data supports potential of monthly hormone-free contraceptive

ByJoshua Fitch, Senior Editor
May 13th 2026
Contraceptive vaginal system for use up to 1 year launches in Canada | Image Credit: © LIGHTFIELD STUDIOS - © LIGHTFIELD STUDIOS - stock.adobe.com.

Contraceptive vaginal system for use up to 1 year launches in Canada

ByJoshua Fitch, Senior Editor
April 7th 2026
How to avoid barriers for user-administered injectable contraceptives, with Jennifer Karlin, MD, PhD

How to avoid barriers for user-administered injectable contraceptives, with Jennifer Karlin, MD, PhD

ByJennifer Karlin, MD, PhD
February 16th 2026

Latest CME

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women
Video

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

View more
Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

Mark Simon, MD, MMM, on the OB hospitalist care model

2

Better decision aids needed for individualized HRT counseling, expert argues

3

When to refer bladder symptoms in ob-gyn practice—and why young age is not reassuring

4

Bowel-prompted delivery in gastroschisis not associated with improved neonatal outcomes, 20-year study finds

5

Contraception counseling is essential at GLP-1 RA initiation in reproductive-age patients

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us